Bone changes from prostaglandin therapy.
Prostaglandin E therapy in infants causes periosteal elevation. Although the changes usually take 30-40 days to become visible, we have seen them as early as nine days. In 15 infants who had prostaglandin E therapy for over six days, three developed periosteal elevation. Three other cases are described in greater detail, with long-term follow-up in two in which the bone remodeled to normal. Gallium scan in one showed increased uptake in areas involved. The periosteal cloaking may mimic Caffey disease but the pattern of involvement is different, since the mandible, which is commonly affected in Caffey disease, is rarely involved in prostaglandin E therapy.
D001842:Bone and Bones / Q000000981:diagnostic imaging; D004374:Ductus Arteriosus, Patent / Q000188:drug therapy; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D010521:Periosteum / Q000187:drug effects*; D011458:Prostaglandins E / Q000009:adverse effects* / Q000627:therapeutic use; D011859:Radiography; D013997:Time Factors
D011458:Prostaglandins E